MAPK7 and triple-negative breast carcinoma: The ERK5 and AKT pathways are known to transactivate each other and regulate cell survival via phosphorylation and cytosolic sequestration of the pro-apoptotic protein Bad in triple negative breast cancer (TNBC) [30].